MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancers.
Wyce A, Matteo JJ, Foley SW, Felitsky DJ, Rajapurkar SR, Zhang XP, Musso MC, Korenchuk S, Karpinich NO, Keenan KM, Stern M, Mathew LK, McHugh CF, McCabe MT, Tummino PJ, Kruger RG, Carpenter C, Barbash O.
Wyce A, et al. Among authors: keenan km.
Oncogenesis. 2018 Apr 20;7(4):35. doi: 10.1038/s41389-018-0043-9.
Oncogenesis. 2018.
PMID: 29674704
Free PMC article.